Is-there a place for vagus nerve stimulation in inflammatory bowel diseases?
暂无分享,去创建一个
[1] V. Sinniger,et al. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease , 2017, Journal of internal medicine.
[2] H. Souza. Etiopathogenesis of inflammatory bowel disease: today and tomorrow. , 2017 .
[3] K. Tracey,et al. Bioelectronic medicine: technology targeting molecular mechanisms for therapy , 2017, Journal of internal medicine.
[4] Zhaohong Shi,et al. Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis. , 2017, American journal of physiology. Gastrointestinal and liver physiology.
[5] S. Hanauer,et al. Optimizing pharmacologic management of inflammatory bowel disease , 2017, Expert review of clinical pharmacology.
[6] R. Stornetta,et al. C1 neurons mediate a stress-induced anti-inflammatory reflex in mice , 2017, Nature Neuroscience.
[7] Robert L. Rennaker,et al. Parametric characterization of neural activity in the locus coeruleus in response to vagus nerve stimulation , 2017, Experimental Neurology.
[8] B. Devaux,et al. Vagus Nerve Stimulation Removal or Replacement Involving the Lead and the Electrode: Surgical Technique, Institutional Experience and Outcome. , 2017, World neurosurgery.
[9] J. Chao,et al. Costs of providing infusion therapy for patients with inflammatory bowel disease in a hospital-based infusion center setting , 2017, Journal of medical economics.
[10] C. Selinger,et al. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions , 2017, Expert review of gastroenterology & hepatology.
[11] H. D. de Souza,et al. Etiopathogenesis of inflammatory bowel disease: today and tomorrow. , 2017, Current opinion in gastroenterology.
[12] D. Martelli,et al. The splanchnic anti‐inflammatory pathway: could it be the efferent arm of the inflammatory reflex? , 2016, Experimental physiology.
[13] S. Bonovas,et al. Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[14] P. Aubert,et al. Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model , 2016, The Journal of physiology.
[15] Ashesh D. Mehta,et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis , 2016, Proceedings of the National Academy of Sciences.
[16] C. Picq,et al. Chronic vagus nerve stimulation in Crohn's disease: a 6‐month follow‐up pilot study , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[17] M. Silverberg,et al. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study , 2016, Inflammatory bowel diseases.
[18] R. Hauger,et al. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture‐Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial , 2016, Neuromodulation : journal of the International Neuromodulation Society.
[19] K. Rijkers,et al. Morphology of the human cervical vagus nerve: implications for vagus nerve stimulation treatment , 2016, Acta neurologica Scandinavica.
[20] S. Kane,et al. Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies , 2015, Inflammatory bowel diseases.
[21] Minhu Chen,et al. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence. , 2015, Journal of Crohn's & colitis.
[22] J. Ellrich,et al. Non-invasive Access to the Vagus Nerve Central Projections via Electrical Stimulation of the External Ear: fMRI Evidence in Humans , 2015, Brain Stimulation.
[23] Esther Tompkins,et al. Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment , 2015, Neurology.
[24] A. Dignass,et al. Complementary therapies in inflammatory bowel diseases. , 2014, Current drug targets.
[25] B. Bonaz,et al. Relationship between Vagal Tone, Cortisol, TNF-Alpha, Epinephrine and Negative Affects in Crohn’s Disease and Irritable Bowel Syndrome , 2014, PloS one.
[26] Michael A. Faltys,et al. Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Ameliorates Disease in Rat Collagen-Induced Arthritis , 2014, PloS one.
[27] G. Boeckxstaens,et al. Neuro-Anatomical Evidence Indicating Indirect Modulation of Macrophages by Vagal Efferents in the Intestine but Not in the Spleen , 2014, PloS one.
[28] U. Kopylov,et al. Optimizing anti-TNF treatments in inflammatory bowel disease. , 2014, Autoimmunity reviews.
[29] O. Palsson,et al. Gut‐directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[30] T. Wang,et al. Involvement of MAPK/NF-κB Signaling in the Activation of the Cholinergic Anti-Inflammatory Pathway in Experimental Colitis by Chronic Vagus Nerve Stimulation , 2013, PloS one.
[31] C. Picq,et al. Vagus nerve stimulation: from epilepsy to the cholinergic anti‐inflammatory pathway , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[32] Wei He,et al. Transcutaneous Auricular Vagus Nerve Stimulation Protects Endotoxemic Rat from Lipopolysaccharide-Induced Inflammation , 2012, Evidence-based complementary and alternative medicine : eCAM.
[33] P. G. Larsson,et al. Application of a computational model of vagus nerve stimulation , 2012, Acta neurologica Scandinavica.
[34] J. Ellrich,et al. Transcutaneous vagus nerve stimulation (t‐VNS) in pharmacoresistant epilepsies: A proof of concept trial , 2012, Epilepsia.
[35] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[36] Antonio Paparelli,et al. The chemical neuroanatomy of vagus nerve stimulation , 2011, Journal of Chemical Neuroanatomy.
[37] P. Pickkers,et al. α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-α production and lung injury. , 2011, British journal of anaesthesia.
[38] O. Devinsky,et al. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. , 2011, Journal of neurosurgery. Pediatrics.
[39] O. Devinsky,et al. Efficacy of vagus nerve stimulation over time: Review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS >10years , 2011, Epilepsy & Behavior.
[40] Bruno Bonaz,et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease , 2011, Autonomic Neuroscience.
[41] E. Szigethy,et al. Inflammatory bowel disease. , 2011, Pediatric clinics of North America.
[42] A. Milby,et al. Vagus nerve stimulation for epilepsy and depression , 2011, Neurotherapeutics.
[43] Olivier David,et al. Dynamic Causal Modelling and physiological confounds: A functional MRI study of vagus nerve stimulation , 2010, NeuroImage.
[44] B. Bonaz,et al. Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome , 2010, Psychoneuroendocrinology.
[45] Ming D. Li,et al. Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor , 2010, Journal of Neuroimmune Pharmacology.
[46] V. Pavlov,et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway , 2009, Brain, Behavior, and Immunity.
[47] Kevin J. Tracey,et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia , 2008, Proceedings of the National Academy of Sciences.
[48] Michael L. Levy,et al. Vagus Nerve Stimulation , 2008, Proceedings of the IEEE.
[49] Samia Mora,et al. Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms , 2007, Circulation.
[50] J. Britton,et al. Vagus nerve stimulation for epilepsy: is output current correlated with acute response? , 2007, Acta neurologica Scandinavica.
[51] Douglas C. Smith,et al. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat , 2006, Brain Research.
[52] S. Collins,et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. , 2006, Gastroenterology.
[53] A. Dorr,et al. Effect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission , 2006, Journal of Pharmacology and Experimental Therapeutics.
[54] Viktoria Osharina,et al. Autonomic response and Fos expression in the NTS following intermittent vagal stimulation: Importance of pulse frequency , 2006, Autonomic Neuroscience.
[55] T. van der Poll,et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. , 2006, Gastroenterology.
[56] C. Dejong,et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve , 2005, The Journal of experimental medicine.
[57] Terry L. Powley,et al. The fiber composition of the abdominal vagus of the rat , 2004, Anatomy and Embryology.
[58] Hong Wang,et al. The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation , 2003, Molecular medicine.
[59] K. Jacobson,et al. Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats , 2003, Autonomic Neuroscience.
[60] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.
[61] Z. Nahas,et al. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. , 2002, Journal of psychiatric research.
[62] E. Peuker,et al. The nerve supply of the human auricle , 2002, Clinical anatomy.
[63] S. Krahl,et al. Destruction of Peripheral C‐Fibers Does Not Alter Subsequent Vagus Nerve Stimulation‐Induced Seizure Suppression in Rats , 2001, Epilepsia.
[64] R. Lynn,et al. Prospective survey of childhood inflammatory bowel disease in the British Isles , 2001, The Lancet.
[65] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[66] Wade M. Mueller,et al. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy , 1999, Neurology.
[67] G. Morris,et al. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. , 1999, Neurology.
[68] K. Vonck,et al. Vagus Nerve Stimulation for Medically Refractory Epilepsy; Efficacy and Cost-Benefit Analysis , 1999, Acta Neurochirurgica.
[69] S. Krahl,et al. Locus Coeruleus Lesions Suppress the Seizure‐Attenuating Effects of Vagus Nerve Stimulation , 1998, Epilepsia.
[70] K. Tracey. Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493. , 1998, Progress in clinical and biological research.
[71] E. Benarroch. The central autonomic network: functional organization, dysfunction, and perspective. , 1993, Mayo Clinic proceedings.
[72] N. Mizuno,et al. Central distribution of primary afferent fibers in the Arnold's nerve (the auricular branch of the vagus nerve): A transganglionic HRP study in the cat , 1984, Brain Research.
[73] G. Harris. The hypothalamus and endocrine glands. , 1950, British medical bulletin.
[74] J. Laux,et al. ANATOMIE MEDICO-CHIRURGICALE DU SYSTEME NERVEUX VEGETATIF. SYMPATHIQUE ET PARASYMPATHIQUE , 1934 .
[75] H. S. Gasser,et al. The Action Potential in Fibers of Slow Conduction in Spinal Roots and Somatic Nerves. , 1929 .